These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15648198)

  • 21. Cancer today and cancer tomorrow: analysis of US cancer claims, 2007-2017.
    Gelburd R
    Am J Manag Care; 2018 Dec; 24(13 Spec No.):SP538-SP541. PubMed ID: 30556682
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening mammography and public health policy: the need for perspective.
    Wright CJ; Mueller CB
    Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International programs for the detection of breast cancer.
    Smith RA
    Salud Publica Mex; 2011; 53(5):394-404. PubMed ID: 22218793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer screening - principles, evaluation and implementation].
    Egger M; Zwahlen M; Cerny T
    Ther Umsch; 2013 Apr; 70(4):195-203. PubMed ID: 23535546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of insurance with cancer care utilization and outcomes.
    Ward E; Halpern M; Schrag N; Cokkinides V; DeSantis C; Bandi P; Siegel R; Stewart A; Jemal A
    CA Cancer J Clin; 2008; 58(1):9-31. PubMed ID: 18096863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the resource implications of extending routine invitation to breast screening to women aged 65-67 years.
    van der Pol M; Cairns J
    Eur J Cancer; 2001 Sep; 37(14):1790-6. PubMed ID: 11549433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for cancer. Is it useful?
    Loefler IJ
    East Afr Med J; 1994 May; 71(5):323-7. PubMed ID: 7925066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing cancer: using health dollars wisely.
    Wasserman S
    NCSL Legisbrief; 2004 Feb; 12(8):1-2. PubMed ID: 14974484
    [No Abstract]   [Full Text] [Related]  

  • 35. Examining the cost-effectiveness of cancer screening promotion.
    Andersen MR; Urban N; Ramsey S; Briss PA
    Cancer; 2004 Sep; 101(5 Suppl):1229-38. PubMed ID: 15316909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests.
    Black WC
    J Clin Oncol; 2006 Jul; 24(20):3252-60. PubMed ID: 16829649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to overcome barriers to early detection of cancer among older adults.
    Rubenstein L
    Cancer; 1994 Oct; 74(7 Suppl):2190-3. PubMed ID: 8087790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for prostate cancer. A decision analytic view.
    Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
    JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of cancer.
    Cromwell J; Gertman P
    Laryngoscope; 1979 Mar; 89(3):393-409. PubMed ID: 107379
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.